Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.250 | 0.250 | 0.000 |
Shares | 99.750 | 99.750 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.610 | 20.305 |
Price to Book | 4.346 | 3.920 |
Price to Sales | 2.689 | 2.654 |
Price to Cash Flow | 15.051 | 14.268 |
Dividend Yield | 1.474 | 1.570 |
5 Years Earnings Growth | 11.673 | 12.072 |
Name | Net % | Category Average |
---|---|---|
Technology | 35.210 | 28.592 |
Financial Services | 13.180 | 16.694 |
Healthcare | 12.410 | 12.750 |
Communication Services | 7.920 | 8.241 |
Industrials | 7.250 | 8.577 |
Consumer Cyclical | 7.210 | 10.069 |
Consumer Defensive | 6.590 | 5.587 |
Energy | 4.430 | 3.432 |
Basic Materials | 2.260 | 2.794 |
Real Estate | 2.260 | 2.398 |
Utilities | 1.280 | 2.384 |
Number of long holdings: 324
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.61 | 430.18 | -0.19% | |
Apple | US0378331005 | 8.66 | 241.84 | +0.94% | |
NVIDIA | US67066G1040 | 8.52 | 139.10 | +0.34% | |
Alphabet A | US02079K3059 | 3.16 | 171.14 | -0.20% | |
Alphabet C | US02079K1079 | 2.67 | 172.75 | -0.13% | |
Eli Lilly | US5324571083 | 2.03 | 812.28 | +1.56% | |
JPMorgan | US46625H1005 | 1.80 | 245.50 | -0.30% | |
Exxon Mobil | US30231G1022 | 1.61 | 118.30 | +0.38% | |
Tesla | US88160R1014 | 1.55 | 348.98 | -2.27% | |
UnitedHealth | US91324P1021 | 1.39 | 606.85 | -0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BMTD2J60 | 1.27B | 18.33 | 15.41 | - | ||
IE00BNNLSM87 | 707.85M | 31.04 | 23.24 | - | ||
IE00BMTD2S51 | 173.34M | 25.85 | 4.90 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review